Immunoassay Reagent Alinity i Hepatitis C Virus (Anti-HCV) CLIA Non-Waived For Alinity i System 200 Tests

Features

• Anti-HCV Next assay is a chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of antibodies to hepatitis C virus (anti-HCV) in human adult serum (collected in serum and serum separator tubes) and plasma (collected in sodium heparin, lithium heparin, lithium heparin separator, sodium citrate, disodium EDTA, tripotassium EDTA, dipotassium EDTA, and dipotassium EDTA separator tubes) on the Alinity i system
• The Anti-HCV Next assay results, in conjunction with other laboratory results and clinical information, may be used to aid in the presumptive diagnosis of hepatitis C virus (HCV) infection in persons with signs and symptoms of hepatitis, persons at risk for HCV infection, and pregnant women
• 6.6 mL Microparticles, 4.2 mL Conjugate 1, 5.9 mL Assay Diluent, 6.1 mL Conjugate 2, Microparticles
• More …